Breast cancer trial with erythropoietin terminated unexpectedly

Lancet Oncol. 2003 Aug;4(8):459-60. doi: 10.1016/s1470-2045(03)01163-x.
No abstract available

MeSH terms

  • Anemia / drug therapy*
  • Anemia / etiology
  • Anemia / prevention & control
  • Breast Neoplasms / complications
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / mortality*
  • Erythropoietin / adverse effects
  • Erythropoietin / therapeutic use*
  • Female
  • Humans
  • Multicenter Studies as Topic
  • Randomized Controlled Trials as Topic
  • Recombinant Proteins
  • Survival Rate

Substances

  • Recombinant Proteins
  • Erythropoietin